TerminatedNCT02140788

Metformin for schizophrenia

This study was terminated. It is testing metformin for schizophrenia.

Schizophrenia, Schizo-affective DisorderDrugFrom 18 Years to 60 Years

The study in practice

Understand this study

This study is for people with schizophrenia. Listed age limits: 18 years to 60 years. Other eligibility criteria apply.

Compensation and expense reimbursement have not been verified for this summary.

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Study start dateMay 2011

Recruitment status: Terminated
Enrollment listed in the registry: 34
Sponsor: Duke University
Sponsor type: University
Study type: Drug
Intervention type: Medication / drug
Study phase: Phase 4
Locations: Not clearly listed
Age range: From 18 Years to 60 Years
Official registry ID: NCT02140788
Official title: A Comparison Of The Effects Of Added Metformin (Versus No Added Metformin) On Psychopathology, Lipids, And Measures of Inflammation During The Initiation Or Re-Institution Of Treatment With Clozapine In Patients With Schizophrenia Or Schizoaffective Disorder

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Study ID: NCT02140788. We help you review the study, but cannot decide medical eligibility.

Terminated

Locations not listed

FAQ

Who is behind this study?

The study sponsor is Duke University, a university.

Does this study involve medication?

Yes. The study involves medication, including Metformin and Fish Oil.

Who can participate?

This study is for people with schizophrenia. Listed age limits: 18 years to 60 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as terminated.

Explore other studies

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.